全文获取类型
收费全文 | 1281208篇 |
免费 | 97604篇 |
国内免费 | 1621篇 |
专业分类
耳鼻咽喉 | 16699篇 |
儿科学 | 41616篇 |
妇产科学 | 35646篇 |
基础医学 | 191531篇 |
口腔科学 | 36294篇 |
临床医学 | 118774篇 |
内科学 | 251346篇 |
皮肤病学 | 28137篇 |
神经病学 | 103456篇 |
特种医学 | 47409篇 |
外国民族医学 | 265篇 |
外科学 | 181951篇 |
综合类 | 25835篇 |
一般理论 | 578篇 |
预防医学 | 105550篇 |
眼科学 | 28722篇 |
药学 | 93596篇 |
6篇 | |
中国医学 | 2081篇 |
肿瘤学 | 70941篇 |
出版年
2019年 | 10776篇 |
2018年 | 14481篇 |
2017年 | 11052篇 |
2016年 | 11922篇 |
2015年 | 13949篇 |
2014年 | 19116篇 |
2013年 | 28867篇 |
2012年 | 39862篇 |
2011年 | 42389篇 |
2010年 | 24441篇 |
2009年 | 23464篇 |
2008年 | 39769篇 |
2007年 | 42407篇 |
2006年 | 41883篇 |
2005年 | 40867篇 |
2004年 | 38967篇 |
2003年 | 37230篇 |
2002年 | 36008篇 |
2001年 | 56054篇 |
2000年 | 57000篇 |
1999年 | 47892篇 |
1998年 | 12596篇 |
1997年 | 11449篇 |
1996年 | 11830篇 |
1995年 | 11970篇 |
1994年 | 11161篇 |
1993年 | 10439篇 |
1992年 | 38195篇 |
1991年 | 37728篇 |
1990年 | 36478篇 |
1989年 | 35282篇 |
1988年 | 32697篇 |
1987年 | 32053篇 |
1986年 | 30535篇 |
1985年 | 28794篇 |
1984年 | 21956篇 |
1983年 | 19174篇 |
1982年 | 11352篇 |
1979年 | 20906篇 |
1978年 | 15389篇 |
1977年 | 12750篇 |
1976年 | 11811篇 |
1975年 | 12790篇 |
1974年 | 15570篇 |
1973年 | 15346篇 |
1972年 | 14505篇 |
1971年 | 13547篇 |
1970年 | 12761篇 |
1969年 | 12065篇 |
1968年 | 11218篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
3.
In 2019, the scientists who discovered how cells sense and adapt to oxygen availability were awarded the Nobel Prize. This elegant sensing pathway is conserved throughout evolution, and it underpins the physiology and pathology that we, as clinicians in anaesthesia and critical care, encounter on a daily basis. The purpose of this review is to bring hypoxia-inducible factor, and the oxygen-sensing pathway as a whole, to the wider clinical community. We describe how this unifying mechanism was discovered, and how it orchestrates diverse changes such as erythropoiesis, ventilatory acclimatisation, pulmonary vascular remodelling and altered metabolism. We explore the lessons learnt from genetic disorders of oxygen sensing, and the wider implications in evolution of all animal species, including our own. Finally, we explain how this pathway is relevant to our clinical practice, and how it is being manipulated in new treatments for conditions such as cancer, anaemia and pulmonary hypertension. 相似文献
4.
Byrne Emma Abel Stephen Yu Alexander Shepard Matthew Karlovits Stephen M. Wegner Rodney E. 《Journal of neuro-oncology》2022,157(1):197-205
Journal of Neuro-Oncology - Adjuvant radiation is often used in patients with low grade gliomas with high-risk characteristics with a recommended dose of 45–54 Gy. We used the... 相似文献
5.
6.
7.
Brain Topography - Accurate cortical source localization of event-related potentials (ERPs) requires using realistic head models constructed from the participant’s structural magnetic... 相似文献
8.
Malou A.H. Nuijten Thijs M.H. Eijsvogels Valerie M. Monpellier Ignace M.C. Janssen Eric J. Hazebroek Maria T.E. Hopman 《Obesity reviews》2022,23(1):e13370
Postbariatric loss of muscle tissue could negatively affect long-term health due to its role in various bodily processes, such as metabolism and functional capacity. This meta-analysis aimed to unravel time-dependent changes in the magnitude and progress of lean body mass (LBM), fat-free mass (FFM), and skeletal muscle mass (SMM) loss following bariatric surgery. A systematic literature search was conducted in Pubmed, Embase, and Web of Science. Fifty-nine studies assessed LBM (n = 37), FFM (n = 20), or SMM (n = 3) preoperatively and ≥1 time points postsurgery. Random-effects meta-analyses were performed to determine pooled loss per outcome parameter and follow-up time point. At 12-month postsurgery, pooled LBM loss was ?8.13 kg [95%CI ?9.01; ?7.26]. FFM loss and SMM loss were ?8.23 kg [95%CI ?10.74; ?5.73] and ?3.18 kg [95%CI ?5.64; ?0.71], respectively. About 55% of 12-month LBM loss occurred within 3-month postsurgery, followed by a more gradual decrease up to 12 months. Similar patterns were seen for FFM and SMM. In conclusion, >8 kg of LBM and FFM loss was observed within 1-year postsurgery. LBM, FFM, and SMM were predominantly lost within 3-month postsurgery, highlighting that interventions to mitigate such losses should be implemented perioperatively. 相似文献
9.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
10.